 Liset Olarte Carhuaz
Concepts (100)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pneumococcal Infections | 10 | 2022 | 16 | 5.300 |
Why?
| | Streptococcus pneumoniae | 11 | 2021 | 16 | 4.970 |
Why?
| | Pneumococcal Vaccines | 10 | 2022 | 14 | 4.460 |
Why?
| | Serogroup | 4 | 2018 | 4 | 1.580 |
Why?
| | Anti-Bacterial Agents | 8 | 2019 | 245 | 1.230 |
Why?
| | Meningitis, Bacterial | 2 | 2019 | 6 | 0.860 |
Why?
| | Meningitis, Pneumococcal | 3 | 2019 | 3 | 0.860 |
Why?
| | Vaccines, Conjugate | 2 | 2018 | 3 | 0.850 |
Why?
| | Humans | 17 | 2022 | 6129 | 0.840 |
Why?
| | Male | 13 | 2018 | 3180 | 0.790 |
Why?
| | Drug Resistance, Multiple, Bacterial | 2 | 2019 | 13 | 0.780 |
Why?
| | Infant | 8 | 2018 | 1389 | 0.770 |
Why?
| | Serotyping | 5 | 2018 | 6 | 0.730 |
Why?
| | Female | 12 | 2018 | 3284 | 0.710 |
Why?
| | Vancomycin | 1 | 2019 | 18 | 0.710 |
Why?
| | Arthritis, Infectious | 1 | 2017 | 3 | 0.660 |
Why?
| | Osteomyelitis | 1 | 2017 | 7 | 0.650 |
Why?
| | United States | 5 | 2018 | 630 | 0.650 |
Why?
| | Pneumonia, Pneumococcal | 1 | 2017 | 1 | 0.640 |
Why?
| | Child, Preschool | 6 | 2017 | 1465 | 0.630 |
Why?
| | Microbial Sensitivity Tests | 4 | 2019 | 37 | 0.620 |
Why?
| | Organ Transplantation | 1 | 2016 | 6 | 0.610 |
Why?
| | Hematopoietic Stem Cell Transplantation | 1 | 2016 | 49 | 0.580 |
Why?
| | Hospitalization | 1 | 2017 | 183 | 0.550 |
Why?
| | Sinusitis | 1 | 2014 | 6 | 0.530 |
Why?
| | Child | 7 | 2022 | 3004 | 0.520 |
Why?
| | Adolescent | 7 | 2017 | 2015 | 0.500 |
Why?
| | Bartonella | 1 | 2012 | 1 | 0.450 |
Why?
| | Bartonella Infections | 1 | 2012 | 1 | 0.450 |
Why?
| | Endocarditis, Bacterial | 1 | 2012 | 1 | 0.450 |
Why?
| | Heart Defects, Congenital | 1 | 2012 | 74 | 0.410 |
Why?
| | Prospective Studies | 4 | 2016 | 489 | 0.400 |
Why?
| | Ceftriaxone | 2 | 2019 | 16 | 0.330 |
Why?
| | Hospitals, Pediatric | 2 | 2018 | 178 | 0.290 |
Why?
| | Incidence | 2 | 2016 | 129 | 0.270 |
Why?
| | Bacteremia | 2 | 2016 | 27 | 0.260 |
Why?
| | Infant, Newborn | 3 | 2018 | 809 | 0.260 |
Why?
| | Retrospective Studies | 2 | 2017 | 1232 | 0.230 |
Why?
| | Young Adult | 3 | 2015 | 607 | 0.230 |
Why?
| | Medicine | 1 | 2022 | 7 | 0.220 |
Why?
| | Immunocompromised Host | 2 | 2022 | 9 | 0.210 |
Why?
| | Antibodies, Bacterial | 2 | 2012 | 8 | 0.200 |
Why?
| | Drug Therapy, Combination | 1 | 2019 | 41 | 0.180 |
Why?
| | Cephalosporins | 1 | 2019 | 17 | 0.180 |
Why?
| | Brucellosis | 2 | 2009 | 2 | 0.180 |
Why?
| | Cohort Studies | 2 | 2016 | 254 | 0.170 |
Why?
| | Drug Resistance, Bacterial | 1 | 2017 | 15 | 0.160 |
Why?
| | Middle Aged | 3 | 2015 | 553 | 0.160 |
Why?
| | Comorbidity | 1 | 2017 | 64 | 0.160 |
Why?
| | Penicillins | 1 | 2016 | 7 | 0.150 |
Why?
| | Bacterial Capsules | 1 | 2016 | 2 | 0.150 |
Why?
| | Immunization Schedule | 1 | 2016 | 8 | 0.150 |
Why?
| | Multilocus Sequence Typing | 1 | 2016 | 4 | 0.150 |
Why?
| | Recurrence | 1 | 2016 | 115 | 0.150 |
Why?
| | Prevalence | 1 | 2016 | 141 | 0.150 |
Why?
| | Genotype | 1 | 2016 | 297 | 0.140 |
Why?
| | Adult | 3 | 2015 | 1121 | 0.140 |
Why?
| | Streptococcus | 1 | 2015 | 3 | 0.140 |
Why?
| | Texas | 1 | 2014 | 18 | 0.130 |
Why?
| | Sepsis | 1 | 2015 | 23 | 0.130 |
Why?
| | Endoscopy | 1 | 2014 | 16 | 0.130 |
Why?
| | Streptococcal Infections | 1 | 2015 | 20 | 0.130 |
Why?
| | Aged | 1 | 2015 | 296 | 0.130 |
Why?
| | Chronic Disease | 1 | 2014 | 104 | 0.130 |
Why?
| | Heptavalent Pneumococcal Conjugate Vaccine | 1 | 2013 | 1 | 0.120 |
Why?
| | Polysaccharides, Bacterial | 1 | 2013 | 1 | 0.120 |
Why?
| | Utah | 1 | 2013 | 1 | 0.120 |
Why?
| | Critical Care | 1 | 2013 | 13 | 0.120 |
Why?
| | Uveitis | 2 | 2009 | 2 | 0.110 |
Why?
| | Infant Welfare | 1 | 2011 | 1 | 0.110 |
Why?
| | Social Responsibility | 1 | 2011 | 1 | 0.110 |
Why?
| | Suburban Health | 1 | 2011 | 1 | 0.110 |
Why?
| | Drug Resistance, Microbial | 1 | 2011 | 4 | 0.110 |
Why?
| | Physician's Role | 1 | 2011 | 6 | 0.110 |
Why?
| | Cross-Sectional Studies | 1 | 2013 | 292 | 0.110 |
Why?
| | Polymerase Chain Reaction | 1 | 2012 | 84 | 0.110 |
Why?
| | Inappropriate Prescribing | 1 | 2011 | 27 | 0.110 |
Why?
| | Health Promotion | 1 | 2011 | 51 | 0.100 |
Why?
| | Practice Patterns, Physicians' | 1 | 2011 | 80 | 0.100 |
Why?
| | Aqueous Humor | 1 | 2009 | 1 | 0.090 |
Why?
| | Brucella melitensis | 1 | 2009 | 1 | 0.090 |
Why?
| | Eye Diseases | 1 | 2008 | 1 | 0.090 |
Why?
| | Peru | 3 | 2011 | 3 | 0.070 |
Why?
| | Vaccination | 1 | 2022 | 63 | 0.050 |
Why?
| | Quality Improvement | 1 | 2022 | 59 | 0.050 |
Why?
| | Twins | 1 | 2015 | 4 | 0.030 |
Why?
| | Dermatitis | 1 | 2011 | 1 | 0.030 |
Why?
| | Bronchitis | 1 | 2011 | 2 | 0.030 |
Why?
| | Diarrhea, Infantile | 1 | 2011 | 3 | 0.030 |
Why?
| | Common Cold | 1 | 2011 | 3 | 0.030 |
Why?
| | Drug Utilization | 1 | 2011 | 14 | 0.030 |
Why?
| | Urinary Tract Infections | 1 | 2011 | 21 | 0.030 |
Why?
| | Pharyngitis | 1 | 2011 | 14 | 0.030 |
Why?
| | Follow-Up Studies | 1 | 2011 | 302 | 0.020 |
Why?
| | Agglutination Tests | 1 | 2009 | 2 | 0.020 |
Why?
| | Immunoglobulin G | 1 | 2009 | 33 | 0.020 |
Why?
| | Biopsy | 1 | 2009 | 55 | 0.020 |
Why?
| | Sensitivity and Specificity | 1 | 2009 | 140 | 0.020 |
Why?
| | Panuveitis | 1 | 2008 | 1 | 0.020 |
Why?
| | Blindness | 1 | 2008 | 2 | 0.020 |
Why?
|
|
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|